We are TAE Life Sciences
TAE Life Sciences (TLS) is a biologically-targeted radiation therapy company focused on developing novel treatment to improve the lives of patients with difficult-to-treat cancers.
A Total Solution
TAE Life Sciences is pushing the boundaries of science to create an innovative biologically targeted radiation therapy for cancer. We are the only company developing both the targeted boron drugs and a neutron beam system for BNCT.
We believe the evolution in BNCT will enable a paradigm shift in cancer care with the potential to improve the lives of patients with difficult-to-treat cancers.
Leadership Team
Robert Hill
Chief Executive Officer
Kendall Morrison, PhD
Chief Science Officer
Anna Theriault
GM Americas and Global Vice President Marketing
Chad Lee, PhD
VP Product
Michael Sandhu
GM EMEAI
Peter Stafford
GM APACBoard of Directors
Robert Hill
Chief Executive Officer, TAE Life Sciences
Michl Binderbauer, PhD
Chief Executive Officer, TAE Technologies, Inc.
Stuart Peterson
Co-Founder and President, ARTIS Ventures
Dr. Deepak “Dee” Khuntia
Senior Vice President, Medical Affairs & Chief Medical Officer, VarianClinical Advisory Board
Richard Amos, PhD
University College London, UKGarth Cruickshank, MD, PhD
Emeritus Professor of Neurosurgery, University of Birmingham UKDaniel Low, PhD
University of California, Los AngelesHave questions about BNCT? Get answers on our new BNCT Forum